Jean Cadet
Psychiatric/Mental Health · Johns Creek, GANPI 1417485491
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.4% of the total across 214 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 19 manufacturers reported payments, led by Johnson & Johnson at 25.5% of the total. Reporting peaked in 2023 at $2,552 and has fallen 60.5% since, to $1,009 in 2025. Among psychiatric/mental health clinicians in GA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 214 payments — averaging $38.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$2K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$957
- Supernus Pharmaceuticals, Inc.$948
- AbbVie$845
- Alkermes, Inc.$580
- Corium, LLC$579
- plus $2K from 13 others
What the payments were for
- Food & beverage$8,10599%
- Education$521%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 31 | $2,082 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 29 | $957 |
| Supernus Pharmaceuticals, Inc. | 34 | $948 |
| AbbVie | 32 | $845 |
| Alkermes, Inc. | 11 | $580 |
| Corium, LLC | 19 | $579 |
| Axsome Therapeutics, Inc. | 6 | $460 |
| Neurocrine Biosciences, Inc. | 8 | $447 |
| Neos Therapeutics, LP | 15 | $335 |
| Otsuka America Pharmaceutical, Inc. | 12 | $322 |
| Grifols USA, LLC | 1 | $136 |
| Novo Nordisk | 1 | $108 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $99 |
| AstraZeneca | 1 | $76 |
| Lundbeck LLC | 2 | $44 |
| Almatica Pharma LLC | 2 | $42 |
| Idorsia Pharmaceuticals US Inc | 3 | $41 |
| Teva Pharmaceuticals USA, Inc. | 2 | $36 |
| Vanda Pharmaceuticals Inc. | 1 | $21 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- LYBALVI$1,491
- SPRAVATO$998
- CAPLYTA$566
- INVEGA SUSTENNA$518
- Azstarys$374
- VRAYLAR$367
- QELBREE$350
- INGREZZA$251
- Auvelity$234
- Prolastin-C Liquid$136
- Adzenys XR-ODT$122
- REXULTI$115
- RYBELSUS$108
How this compares
$8,157 in reported general payments places this provider in the 95th percentile of 900 psychiatric/mental health providers in Georgia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 51 | $10,417 |
| Quetiapine Fumarate | 31 | $1,023 |
| Duloxetine Hcl | 38 | $726 |
| Trazodone Hcl | 34 | $593 |
| Lamotrigine | 29 | $585 |
| Hydroxyzine Pamoate | 11 | $369 |
| Buspirone Hcl | 18 | $327 |
| Gabapentin | 11 | $266 |
| Bupropion XlBupropion Hcl | 18 | $261 |
| Clonazepam | 48 | $232 |
| Fluoxetine Hcl | 12 | $203 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 22 | $180 |
| Lorazepam | 23 | $125 |
| Escitalopram Oxalate | 17 | $115 |
| Zolpidem Tartrate | 21 | $84 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Almatica Pharma LLCSertraline Hcl | $42 | $4918 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 900 psychiatric/mental health providers in Georgia.
Other psychiatric/mental health in Johns Creek
- Akeela DossaJohns Creek$7K
- Phyillis Kennedy-HowellBarney$673K
- Jessica OliverThomasville$233K
- Sherri KrollBrunswick$155K
- Taylor LeblancAlbany$48K
- Greta HeckmannDalton$28K
- Matthew DowdyWoodstock$25K
- Natasha GilesLoganville$21K
- Darrick SealeyWarner Robins$17K
- Olufunke AdewunmiSmyrna$13K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.